Status:
UNKNOWN
Efficacy of rTMS in the Treatment of Patients With Migraine
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Migraine
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Migraine is a condition thought to be related to cortical hyperexcitability. Repetitive transcranial magnetic stimulation (rTMS) can modulate the cortical excitability by means of long-term potentiati...
Eligibility Criteria
Inclusion
- Age of 18-65 years
- Diagnosed as migraine (with or without aura)
- More than 4 attacks per month for at least 3 months prior to study
- No preventive medication used
- Must be able to sign permit
Exclusion
- History of seizure or family history of seizures
- Women in pregnancy or breast-feeding
- Patient with medication overuse
- Patient with other medical, psychologic, or surgical illness
- Patient under preventive medications
- Prior rTMS examination one month within
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00316979
Start Date
April 1 2006
Last Update
June 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Headache Center, Teipei Veterans General Hospital
Taipei, Taiwan, 112